Compare MGTX & PMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGTX | PMT |
|---|---|---|
| Founded | 2015 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 879.9M |
| IPO Year | 2018 | 2009 |
| Metric | MGTX | PMT |
|---|---|---|
| Price | $14.34 | $9.31 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 5 |
| Target Price | ★ $24.57 | $13.50 |
| AVG Volume (30 Days) | 528.7K | ★ 1.3M |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 13.33% |
| EPS Growth | ★ 33.02 | N/A |
| EPS | ★ 1.30 | 0.40 |
| Revenue | $81,391,000.00 | ★ $351,067,000.00 |
| Revenue This Year | $141.38 | N/A |
| Revenue Next Year | N/A | $1.55 |
| P/E Ratio | ★ $11.18 | $23.48 |
| Revenue Growth | ★ 144.57 | N/A |
| 52 Week Low | $6.62 | $9.05 |
| 52 Week High | $15.35 | $13.80 |
| Indicator | MGTX | PMT |
|---|---|---|
| Relative Strength Index (RSI) | 64.13 | 40.22 |
| Support Level | $7.04 | $9.05 |
| Resistance Level | $15.35 | $9.83 |
| Average True Range (ATR) | 0.67 | 0.20 |
| MACD | 0.18 | 0.02 |
| Stochastic Oscillator | 76.40 | 7.76 |
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
PennyMac Mortgage Investment Trust is a specialty finance company that invests mainly in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.